South Korea's first domestic new crown vaccine is approved and used to apply for WHO licenses

Overseas Network, June 29. According to Yonhap News Agency, on the 29th, the new crown vaccine developed by SK Biological Sciences in South Korea was approved. This is also the first Korean domestic new crown vaccine to be approved.The company stated that it plans to apply for an emergency use list for the WHO.

On the morning of the 29th, the Korean Food and Medical Safety Office held a meeting and decided to approve the GBP510 vaccine of SK Biological Science to put it into use.GBP510 is a restructuring protein vaccine jointly developed by SK Biological Science and the University of Washington University, which can be stored in a refrigerator of 2 ~ 8 ° C.For adults over 18 years old, two doses are vaccinated.

The Yonhap News Agency said that from this, South Korea has the ability to independently develop and produce new crown therapy drugs and vaccines.(Overseas Network Liu Qiang)